6W5 Stock Overview
Provides designs, develops, and markets medical devices for spine worldwide.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
SpineGuard SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.16 |
52 Week High | €0.61 |
52 Week Low | €0.15 |
Beta | 2.28 |
11 Month Change | -26.97% |
3 Month Change | -25.61% |
1 Year Change | -65.16% |
33 Year Change | -86.37% |
5 Year Change | n/a |
Change since IPO | -91.06% |
Recent News & Updates
Recent updates
Shareholder Returns
6W5 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 1.9% | 0.5% | -0.1% |
1Y | -65.2% | 0.9% | 2.4% |
Return vs Industry: 6W5 underperformed the German Medical Equipment industry which returned 0.9% over the past year.
Return vs Market: 6W5 underperformed the German Market which returned 2.4% over the past year.
Price Volatility
6W5 volatility | |
---|---|
6W5 Average Weekly Movement | 15.3% |
Medical Equipment Industry Average Movement | 4.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 6W5's share price has been volatile over the past 3 months.
Volatility Over Time: 6W5's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 22 | Pierre Jérôme | www.spineguard.com |
SpineGuard SA provides designs, develops, and markets medical devices for spine worldwide. The company offers PediGuard drilling instruments comprising straight, curved, cannulated, and threaded PediGuard products; and DSG smart screw that allows for one step screw placement treatment. It also provides DSG (Dynamic Surgical Guidance) Connect app that allows collection and visualization of the signal measured at the tip of DSG Connect devices during pedicle drilling, as well as DSG for orthopedic robots and dental implantology products.
SpineGuard SA Fundamentals Summary
6W5 fundamental statistics | |
---|---|
Market cap | €9.49m |
Earnings (TTM) | -€4.18m |
Revenue (TTM) | €4.31m |
2.1x
P/S Ratio-2.2x
P/E RatioIs 6W5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6W5 income statement (TTM) | |
---|---|
Revenue | €4.31m |
Cost of Revenue | €933.74k |
Gross Profit | €3.38m |
Other Expenses | €7.56m |
Earnings | -€4.18m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 11, 2024
Earnings per share (EPS) | -0.088 |
Gross Margin | 78.35% |
Net Profit Margin | -97.00% |
Debt/Equity Ratio | 48.6% |
How did 6W5 perform over the long term?
See historical performance and comparison